Temple Therapeutics BV

Based in Geleen, Netherlands, Temple Therapeutics BV is a private enterprise specializing in the development of medical treatments for patients with orthopedic conditions, cancer, and endometriosis. Temple Therapeutics is revolutionizing the biotechnology industry with its clinical-stage, independently owned company dedicated to creating a precision medicine approach targeted towards women. They are trailblazers in discovering, developing and marketing innovative therapies and diagnostic tools tailored for early detection and treatment of diseases related to gynecological fibrosis. Temple is driven by a commitment to make medical advancements universally accessible, serving marginalized communities and ensuring availability of safe and effective treatment options through its focus on cutting-edge research and healthcare technology. Temple's portfolio includes therapies for endometriosis, ovarian cancer, and other conditions related to fibrosis in abdominal tissues. Aspiring to be a top player in obstetrics and gynecology biopharma, Temple envisions a world where gynecological health is normalized, early detection enables less invasive treatments, and healthcare is comprehensive, addressing not just physical, but also mental and social well-being.